Aton (BST:3HB)

Germany · Delayed Price · Currency is EUR

0.0090

-0.0002 (-2.17%)

At close: Oct 29, 2026

Market Cap	7.29M +15.8%
Revenue (ttm)	661.00K +7.7%
Net Income	-962.00K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0092
Previous Close	0.0092
Day's Range	0.0090 - 0.0098
52-Week Range	0.0002 - 0.0258
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Aton

Aton operates as a bioscience company in France. It engages in preclinical and clinical services, production of monoclonal antibodies, and laboratory equipment production, as well as provision of human tissues. The company is involved in development of biomaterials and reagents for diagnostics, as well as preclinical research services. Aton was founded in 1998 and is headquartered in Strasbourg, France. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1998

Employees 13

Stock Exchange Stuttgart Stock Exchange

Ticker Symbol 3HB

Financial Performance

In 2025, Aton's revenue was 661,000, an increase of 7.65% compared to the previous year's 614,000. Losses were -962,000, -12.62% less than in 2024.

Financial Statements